Diagnostic Medical Systems SA
Diagnostic Medical Systems S.A. engages in the design, development, manufacture, and sale of medical imaging systems in France. It offers ADAM, in-house software suite; R and F solutions; bone densitometry; chest and bone room; mobile; c-arm; retrofit kit; and mammography equipment. The company was founded in 1979 and is headquartered in Gallargues-le-Montueux, France.
Diagnostic Medical Systems SA (ALDMS) - Total Assets
Latest total assets as of June 2025: €57.17 Million EUR
Based on the latest financial reports, Diagnostic Medical Systems SA (ALDMS) holds total assets worth €57.17 Million EUR as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Diagnostic Medical Systems SA - Total Assets Trend (2009–2024)
This chart illustrates how Diagnostic Medical Systems SA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Diagnostic Medical Systems SA - Asset Composition Analysis
Current Asset Composition (December 2024)
Diagnostic Medical Systems SA's total assets of €57.17 Million consist of 56.2% current assets and 43.8% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 9.9% |
| Accounts Receivable | €8.82 Million | 16.3% |
| Inventory | €14.45 Million | 26.8% |
| Property, Plant & Equipment | €4.51 Million | 8.4% |
| Intangible Assets | €10.72 Million | 19.9% |
| Goodwill | €8.02 Million | 14.9% |
Asset Composition Trend (2009–2024)
This chart illustrates how Diagnostic Medical Systems SA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Diagnostic Medical Systems SA's current assets represent 56.2% of total assets in 2024, a decrease from 85.7% in 2009.
- Cash Position: Cash and equivalents constituted 9.9% of total assets in 2024, down from 11.5% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 33.0% of total assets, an increase from 10.0% in 2009.
- Asset Diversification: The largest asset category is inventory at 26.8% of total assets.
Diagnostic Medical Systems SA Competitors by Total Assets
Key competitors of Diagnostic Medical Systems SA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Diagnostic Medical Systems SA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Diagnostic Medical Systems SA generates 0.85x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Diagnostic Medical Systems SA is currently not profitable relative to its asset base.
Diagnostic Medical Systems SA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.16 | 1.29 | 1.35 |
| Quick Ratio | 0.62 | 0.64 | 0.72 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €4.70 Million | € 6.72 Million | € 6.96 Million |
Diagnostic Medical Systems SA - Advanced Valuation Insights
This section examines the relationship between Diagnostic Medical Systems SA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.69 |
| Latest Market Cap to Assets Ratio | 0.25 |
| Asset Growth Rate (YoY) | 5.5% |
| Total Assets | €53.95 Million |
| Market Capitalization | $13.39 Million USD |
Valuation Analysis
Below Book Valuation: The market values Diagnostic Medical Systems SA's assets below their book value (0.25 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Diagnostic Medical Systems SA's assets grew by 5.5% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Diagnostic Medical Systems SA (2009–2024)
The table below shows the annual total assets of Diagnostic Medical Systems SA from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €53.95 Million | +5.50% |
| 2023-12-31 | €51.14 Million | -5.11% |
| 2022-12-31 | €53.89 Million | +1.63% |
| 2021-12-31 | €53.03 Million | +15.79% |
| 2020-12-31 | €45.80 Million | +13.68% |
| 2019-12-31 | €40.28 Million | +9.35% |
| 2018-12-31 | €36.84 Million | -8.09% |
| 2017-12-31 | €40.08 Million | -19.81% |
| 2016-12-31 | €49.98 Million | +7.66% |
| 2015-12-31 | €46.42 Million | +17.84% |
| 2014-12-31 | €39.40 Million | +67.16% |
| 2013-12-31 | €23.57 Million | +1.77% |
| 2012-12-31 | €23.16 Million | +9.90% |
| 2011-12-31 | €21.07 Million | -2.59% |
| 2010-12-31 | €21.63 Million | +8.53% |
| 2009-12-31 | €19.93 Million | -- |